ARCHIVES

NCI’s use of Cancer Dialogue for biospecimen network blueprint raises legal, procedural questions.

This article is from The Cancer Letter archive.

Vol. 29 No. 46 | December 12, 2003

Download PDF Visit The Full Archive

Related Articles

Half-Percent NIH, NCI Budget Raise Is Not Enough, Advocates Say

December 19, 2014

NCI Programs: NCI Seeks Nominations For director’s Consumer Liaison Group

August 6, 1999

Nader Group Backs FDA In controversy Over Drug Testing

February 11, 1977

Pathology Review Confirms Reserpine As Carcinogen

March 14, 1980

President’s Cancer Panel Seeks Ways to Open Grants For More New Ideas

December 19, 1980

FASEB Urges Congress To Fund Stem Cell Research.

July 27, 2001